The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) ...

Medtronic announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.

Medtronic snagged FDA approval for an expanded indication for its OmniaSecure defibrillation lead. Check out why this tiny ...

Medtronic and Biotronik both took steps forward this week with their pacemaker hardware designed to target newly emerging ...

OmniaSecure is now the first defibrillation lead approved for placement in the left bundle branch.

The US Food and Drug Administration (FDA) has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for insertion in the right ventricle. This new 4.7 French (1.6mm) lead, which ...

A team of researchers from Sergio Arboleda University in Bogotá, Colombia, and the Georgia Institute of Technology in Atlanta utilized an electrophysiological computer model of the heart’s electrical ...

Defibrillation testing of implantable cardioverter–defibrillators (ICDs) does not improve outcomes compared with device implantation without testing and, therefore, “defibrillation testing during ...

When someone has a sudden heart attack, is it better to begin chest compressions first or start by using a defibrillator? Click to read what researchers say. A new study by the University of Michigan ...

The study, published in the New England Journal of Medicine on Nov. 24, studied patient outcomes for three methods of defibrillation: standard defibrillation; double sequential external defibrillation ...

Traditional hospital factors -- such as case volume and academic status -- do not appear to predict whether patients with cardiac arrest at that facility are likely to experience delays in receiving ...